252 related articles for article (PubMed ID: 29424288)
21. Dry powder inhalers - between the doctor and the patient.
Emeryk A; Pirożyński M; Emeryk-Maksymiuk J
Adv Respir Med; 2018; 86(1):44-52. PubMed ID: 29490421
[TBL] [Abstract][Full Text] [Related]
22. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
Zervas E; Samitas K; Gaga M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
[TBL] [Abstract][Full Text] [Related]
23. Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.
Siler TM; Jain R; Collison K; Sharma R; Sutton L; Rees J; Bernstein DI
PLoS One; 2022; 17(8):e0273170. PubMed ID: 35969632
[TBL] [Abstract][Full Text] [Related]
24. Expanded table: Correct use of inhalers for asthma.
Med Lett Drugs Ther; 2020 Dec; 62(1613):e204-e208. PubMed ID: 33446624
[No Abstract] [Full Text] [Related]
25. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
26. Inhaled drug delivery in the hands of the patient.
Lavorini F
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
[TBL] [Abstract][Full Text] [Related]
27. Table: Correct Use of inhalers for COPD.
Med Lett Drugs Ther; 2020 Sep; 62(1606):e150-e154. PubMed ID: 32960876
[No Abstract] [Full Text] [Related]
28. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
Ding B; Small M; Scheffel G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
[TBL] [Abstract][Full Text] [Related]
29. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
30. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
Pepper AN; Cooke A; Livingston L; Lockey RF
Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
[TBL] [Abstract][Full Text] [Related]
31. [Easyhaler--ideal dry powder inhaler].
Andrzej E; Małgorzata BE
Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
[TBL] [Abstract][Full Text] [Related]
32. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
Riley JH; Tabberer M; Richard N; Donald A; Church A; Harris SS
Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
[TBL] [Abstract][Full Text] [Related]
33. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
34. Optimizing drug delivery in COPD: The role of inhaler devices.
Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
[TBL] [Abstract][Full Text] [Related]
35. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
[TBL] [Abstract][Full Text] [Related]
36. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
37. Aerosol Delivery Devices for Obstructive Lung Diseases.
Pleasants RA; Hess DR
Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
[TBL] [Abstract][Full Text] [Related]
38. A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
van der Palen J; Slade D; Rehal S; Verma M; Plank M
Respir Med; 2022 Dec; 205():107031. PubMed ID: 36368290
[TBL] [Abstract][Full Text] [Related]
39. The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler.
Varacca G; D'Angelo D; Glieca S; Cavalieri L; Piraino A; Quarta E; Sonvico F; Buttini F
Eur J Pharm Sci; 2023 Apr; 183():106385. PubMed ID: 36646153
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.
Weers J; Clark A
Pharm Res; 2017 Mar; 34(3):507-528. PubMed ID: 27738953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
